Protective effects of higher levels of innate IgM anti-PC autoantibodies on CVE were detected in younger patients with RA and those at high risk of CVE: males, presence of obesity, and non-remission at 1 year. The gene discussed is CD40LG; the disease is obesity due to melanocortin 4 receptor deficiency.